Strategic Wealth Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $254K | Sell |
3,543
-96
| -3% | -$7.39K | 0.02% | 274 |
|
|
2025
Q4 | $289K | Buy |
3,639
+316
| +10% | +$24.9K | 0.02% | 270 |
|
|
2025
Q3 | $250K | Sell |
3,323
-208
| -6% | -$14.3K | 0.02% | 312 |
|
|
2025
Q2 | $244K | Buy |
+3,531
| New | +$232K | 0.02% | 298 |
|
|
2024
Q4 | $324K | Sell |
4,888
-1,815
| -27% | -$102K | 0.03% | 253 |
|
|
2024
Q3 | $421K | Sell |
6,703
-1,497
| -18% | -$87.3K | 0.04% | 219 |
|
|
2024
Q2 | $484K | Sell |
8,200
-53,739
| -87% | -$3.36M | 0.05% | 198 |
|
|
2024
Q1 | $4.94M | Buy |
61,939
+3,628
| +6% | +$277K | 0.54% | 63 |
|
|
2023
Q4 | $4.6M | Buy |
58,311
+14,691
| +34% | +$1.05M | 0.57% | 63 |
|
|
2023
Q3 | $3.05M | Buy |
43,620
+933
| +2% | +$66.1K | 0.4% | 73 |
|
|
2023
Q2 | $2.95M | Sell |
42,687
-1,002
| -2% | -$71.3K | 0.38% | 79 |
|
|
2023
Q1 | $3.25M | Buy |
43,689
+6,020
| +16% | +$505K | 0.5% | 59 |
|
|
2022
Q4 | $3.51M | Buy |
37,669
+4,374
| +13% | +$422K | 0.65% | 40 |
|
|
2022
Q3 | $3.18M | Buy |
33,295
+1,419
| +4% | +$140K | 0.67% | 39 |
|
|
2022
Q2 | $2.95M | Buy |
31,876
+14,323
| +82% | +$1.4M | 0.64% | 50 |
|
|
2022
Q1 | $1.78M | Buy |
17,553
+1,926
| +12% | +$202K | 0.35% | 97 |
|
|
2021
Q4 | $1.61M | Sell |
15,627
-93
| -0.6% | -$8.59K | 0.31% | 106 |
|
|
2021
Q3 | $1.33M | Buy |
15,720
+3,384
| +27% | +$283K | 0.39% | 72 |
|
|
2021
Q2 | $1.03M | Sell |
12,336
-8,900
| -42% | -$729K | 0.34% | 83 |
|
|
2021
Q1 | $1.6M | Sell |
21,236
-1,146
| -5% | -$83.5K | 0.64% | 37 |
|
|
2020
Q4 | $1.53M | Sell |
22,382
-1,224
| -5% | -$79.6K | 0.64% | 37 |
|
|
2020
Q3 | $1.38M | Sell |
23,606
-5,624
| -19% | -$350K | 0.7% | 38 |
|
|
2020
Q2 | $1.9M | Buy |
29,230
+6,901
| +31% | +$435K | 0.98% | 20 |
|
|
2020
Q1 | $1.66M | Hold |
22,329
| – | – | 0.86% | 27 |
|
|
2019
Q4 | $1.66M | Sell |
22,329
-3,180
| -12% | -$223K | 0.86% | 27 |
|
|
2019
Q3 | $200K | Buy |
25,509
+5,208
| +26% | +$309K | 1.03% | 26 |
|
|
2019
Q2 | $1.11M | Buy |
20,301
+623
| +3% | +$33.5K | 0.53% | 56 |
|
|
2019
Q1 | $1.07M | Buy |
19,678
+2,258
| +13% | +$139K | 0.49% | 64 |
|
|
2018
Q4 | $1.15M | Sell |
17,420
-478
| -3% | -$35.7K | 0.58% | 45 |
|
|
2018
Q3 | $1.41M | Buy |
17,898
+1,285
| +8% | +$91.9K | 0.75% | 36 |
|
|
2018
Q2 | $1.07M | Sell |
16,613
-280
| -2% | -$18.5K | 0.62% | 43 |
|
|
2018
Q1 | $1.05M | Buy |
16,893
+1,907
| +13% | +$137K | 0.54% | 60 |
|
|
2017
Q4 | $1.03M | Buy |
+14,986
| New | +$1.09M | 0.57% | 58 |
|
Other funds holding CVS
VCM
VPM
Strategic Wealth Partners's CVS Position: Q1 2026 in Review
Strategic Wealth Partners reduced its CVS Health (CVS) stake by 2.6% in Q1 2026, selling an estimated $7.39K and leaving 3,543 shares worth $254K. The position accounts for 0.02% of the portfolio, ranked #274.
Strategic Wealth Partners first reported a position in CVS in Q4 2017 and has held it in 33 quarters since. The position peaked at $4.94M in Q1 2024. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Strategic Wealth Partners held 3,543 shares of CVS Health worth $254K as of Q1 2026.
- Strategic Wealth Partners sold 96 CVS Health shares in Q1 2026, an estimated $7.39K.
- CVS Health made up 0.02% of Strategic Wealth Partners's portfolio in Q1 2026, its #274 holding.
- Strategic Wealth Partners first reported a position in CVS Health in Q4 2017 and has held it in 33 quarters since.
- Strategic Wealth Partners's CVS Health position peaked at $4.94M in Q1 2024.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Strategic Wealth Partners's 13F filing for Q1 2026, filed 12 May 2026.